Clinical Trials Sponsored by Capillus, LLC

Total 10735 results

Padagis LLC

Completed

Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

Herpes Labialis

United States
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams

Healthy
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

Healthy
Padagis LLC

Completed

Randomized Study to Compare the Bioequivalence of Two Fluticasone Propionate 0.05% Topical Creams

Healthy
Padagis LLC

Completed

Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

Healthy
Padagis LLC

Completed

Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis

Vulvovaginal Candidiasis
MedImmune LLC

Completed

Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age

Influenza

United States, United Kingdom, Belgium, Czechia, Hong Kong, Ireland, Korea, Republic of, Taiwan
Formula30A LLC

Completed

Anxiety Symptoms in Relation to Use of Hemp-derived, Full Spectrum Cannabidiol (CBD)

Generalized Anxiety Disorder

United States, Puerto Rico
MedImmune LLC

Terminated

A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus (RSV) Illness

Participants Less Than 12 Months of Age With RSV Illness

United States
Avicena LLC

Completed

Vivio AS (Aortic Stenosis) Detection Study

Aortic Stenosis

United States
HepQuant, LLC

Completed

Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation (Repro)

Hepatitis C, Chronic | Non-Alcoholic Fatty Liver Disease

United States
MedImmune LLC

Completed

A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies

Kidney Cancer | Clear Cell Renal Cell Carcinoma | Select Advanced Malignancies

United States, France, Canada, United Kingdom, Netherlands, Australia
MedImmune LLC

Completed

A Phase 1/2 Study to Evaluate MEDI4736

Advanced Solid Tumors

United States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
Mitosynergy LLC

Completed

Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain

Myalgia | Neuralgia

Canada
Bioventus LLC

Completed

Prospective Single Center Open Label Study of Shoulder OA Pain

Osteoarthritis

Canada
Pharmacyclics LLC.

Completed

Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)

Metastatic Pancreatic Adenocarcinoma

Spain, Italy, Korea, Republic of, United States, Belgium, United Kingdom, Germany, France
Lumendi, LLC

Unknown

Registry Evaluation of a Double Balloon Accessory Device

Adenomatous Polyp of Colon

United States
Lumendi, LLC

Unknown

Prospective Study of a New Endolumenal Device Used During Endoscopic Polypectomy in the Colon (DiLumenC2)

Polyps of Colon
MedImmune LLC

Completed

A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).

Asthma

United States, Canada
Promomed, LLC

Completed

Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19

COVID-19

Russian Federation
MedImmune LLC

Withdrawn

Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC

Microsatellite-stable Colorectal Cancer
bioRASI, LLC

Completed

A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea

Papulopustular Rosacea | Erythematotelangiectatic Rosacea

United States
HemoSonics LLC

Completed

QStat Pilot Reference Range Study

Coagulation Disorder

United States
MedImmune LLC

Completed

A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Germany
MedImmune LLC

Completed

A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies

Cancer | B-cell Malignancies

United States, Italy, Belgium, Canada, Spain
Immunitor LLC

Unknown

Immunotherapy of Chronic Kidney Failure

Renal Failure Chronic

Mongolia
MedImmune LLC

Completed

A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated

Renal Insufficiency | Type II Diabetes Mellitus

United Kingdom, Germany
MedImmune LLC

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of MEDI5884 in Adults With Stable Coronary Heart Disease

Stable Coronary Heart Disease

United States
Pharmacyclics LLC.

Completed

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

United States
Belluscura LLC

Completed

Usability Evaluation of a Portable Oxygen Concentrator

Supplemental Oxygen

United States
MedImmune LLC

Completed

A Phase 1/1b Study of MEDI3726 in Adults Subjects With Metastatic Castration Resistant Prostate Cancer (MEDI3726)

Metastatic Castration Resistant Prostate Cancer

United States, Switzerland, United Kingdom
Immunogenics, LLC

Completed

Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]

Celiac Disease

United States
MedImmune LLC

Completed

A Phase 2a Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Adults With Asthma

Asthma

United States
MedImmune LLC

Completed

D2560C00015 FluMist Annual Safety Study 2018

Healthy | Influenza

United States
MedImmune LLC

Completed

A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.

Type 2 Diabetes Mellitus

Germany
Berg, LLC

Completed

BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

Cancer | Solid Tumor | Metastatic Cancer

United States
MedImmune LLC

Completed

A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants. (MEDI8897 Ph2b)

Respiratory Syncytial Virus Infections

United States, Canada, Finland, France, Italy, Spain, Belgium, Hungary, Turkey, United Kingdom, New Zealand, Brazil, South Africa, Australia, Bulgaria, Czechia, Poland, Estonia, Lithuania, Chile, Latvia, Sweden, Argentina
Immunitor LLC

Unknown

Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma (cholangio)

Cholangiocarcinoma

Mongolia
Immunitor LLC

Unknown

Open Label Immunotherapy Trial for Ovarian Cancer (V3-OVA)

Ovarian Cancer

Mongolia
Immunitor LLC

Unknown

Immunotherapy of Cervical Cancer With V3-Cervix (V3-Cervix)

Cervical Cancer

Mongolia
MedImmune LLC

Completed

An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults

Lupus Erythematosus, Systemic

United States, Korea, Republic of, Mexico, Peru, Hungary, Ukraine, Czechia, Bulgaria, Colombia, Brazil, Poland, Romania, Taiwan
Regenexx, LLC

Completed

Catabolic Marker Levels After Platelet Poor Plasma (PPP) Lavage (PPP)

Knee Osteoarthritis

United States
Immunitor LLC

Unknown

V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer (GBM)

Glioblastoma Multiforme | Glioma of Brain

Mongolia
Pharmacyclics LLC.

Completed

Study of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma

Follicular Lymphoma | B-cell Lymphoma | Non-Hodgkin's Lymphoma

United States
MedImmune LLC

Withdrawn

Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

Influenza - Type A Strains
MedImmune LLC

Completed

A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes

Type 2 Diabetes

United States
Berg, LLC

Completed

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

Squamous Cell Carcinoma

United States
MedImmune LLC

Completed

MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)

Diffuse Large B-Cell Lymphoma

United States, France, United Kingdom, Ireland
Lifecells, LLC.

Completed

Study to Assess Efficacy and Safety of Bone Marrow Derived Stem Cells in Patients With Critical Limb Ischemia (CLI)

Critical Limb Ischemia

United States
MedImmune LLC

Completed

Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults

Healthy Volunteer

United Kingdom

3

Subscribe